Literature DB >> 1905327

Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.

M Quiding1, I Nordström, A Kilander, G Andersson, L A Hanson, J Holmgren, C Czerkinsky.   

Abstract

We have examined secretory antibody and cell-mediated immune responses to oral cholera vaccine in the human gastrointestinal mucosa. Freshly isolated peripheral blood lymphocytes and intestinal lymphocytes obtained by enzymatic dispersion of duodenal biopsies were assayed for numbers of total and vaccine specific immunoglobulin-secreting cells by enzyme-linked immunospot assay (ELISPOT) techniques; the frequency of cells secreting interferon-gamma (IFN-gamma) was also examined by a new modification of the ELISPOT technique. After booster immunizations with oral cholera vaccine, large numbers of cholera toxin-specific antibody-secreting cells (ASC) appeared in the small intestine. The responses were dominated by IgA ASC. A single immunization, performed 5 mo after the initial vaccinations, gave rise to an ASC response similar to that seen after the first booster immunization, with respect to both magnitude and isotype distribution. Each of the immunizations also evoked an ASC response in blood which was of lower magnitude than that seen in the small intestine, and comprised similar proportions of IgA and IgG ASC. A booster immunization also resulted in increased frequencies of IFN-gamma-secreting cells, but this increase was confined to the duodenal mucosa. This study establishes the feasibility of studying, at the single-cell level, intestinal immune reactivity in humans. Furthermore, it indicates that the small intestinal mucosa is an enriched source of IFN-gamma. It also demonstrates marked differences between intestinal and peripheral blood immune responses after enteric immunization, and confirms the notion that the mucosal immune system in humans displays immunological memory.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905327      PMCID: PMC296014          DOI: 10.1172/JCI115270

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Gamma-interferon-mediated down-regulation of electrolyte secretion by intestinal epithelial cells: a local immune mechanism?

Authors:  J Holmgren; J Fryklund; H Larsson
Journal:  Scand J Immunol       Date:  1989-10       Impact factor: 3.487

2.  Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans.

Authors:  C Czerkinsky; A M Svennerholm; M Quiding; R Jonsson; J Holmgren
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

3.  Selectively increased production of interferon-gamma by subsets of Lyt-2+ and L3T4+ T cells identified by expression of Pgp-1.

Authors:  R C Budd; J C Cerottini; H R MacDonald
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

4.  A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells.

Authors:  C Czerkinsky; Z Moldoveanu; J Mestecky; L A Nilsson; O Ouchterlony
Journal:  J Immunol Methods       Date:  1988-11-25       Impact factor: 2.303

Review 5.  Interferon-gamma: a review.

Authors:  J N Ijzermans; R L Marquet
Journal:  Immunobiology       Date:  1989-10       Impact factor: 3.144

6.  Normal human intestinal B lymphocytes. Increased activation compared with peripheral blood.

Authors:  M G Peters; H Secrist; K R Anders; G S Nash; S R Rich; R P MacDermott
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

7.  Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells.

Authors:  C Czerkinsky; G Andersson; H P Ekre; L A Nilsson; L Klareskog; O Ouchterlony
Journal:  J Immunol Methods       Date:  1988-05-25       Impact factor: 2.303

8.  Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins.

Authors:  L M Sollid; D Kvale; P Brandtzaeg; G Markussen; E Thorsby
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

9.  Monoclonal antibody two-site ELISA for human IFN-gamma. Adaptation for determinations in human serum or plasma.

Authors:  G Andersson; H P Ekre; G Alm; P Perlmann
Journal:  J Immunol Methods       Date:  1989-12-20       Impact factor: 2.303

10.  Vaccination by non-parenteral routes: characteristics of immune response.

Authors:  P L Ogra; Y Chiba; K R Beutner; A Morag
Journal:  Dev Biol Stand       Date:  1976
View more
  84 in total

1.  Development of a novel in vitro assay (ALS assay) for evaluation of vaccine-induced antibody secretion from circulating mucosal lymphocytes.

Authors:  H S Chang; D A Sack
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

2.  Construction of a Vibrio cholerae vaccine candidate using transposon delivery and FLP recombinase-mediated excision.

Authors:  S L Chiang; J J Mekalanos
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

3.  Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O0139.

Authors:  F Qadri; G Jonson; Y A Begum; C Wennerås; M J Albert; M A Salam; A M Svennerholm
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

4.  A novel retinoic acid, catechin hydrate and mustard oil-based emulsion for enhanced cytokine and antibody responses against multiple strains of HIV-1 following mucosal and systemic vaccinations.

Authors:  Mingke Yu; Michael Vajdy
Journal:  Vaccine       Date:  2011-01-25       Impact factor: 3.641

5.  The distribution of immunoreactive interferon-gamma-containing cells in normal human tissues.

Authors:  F Brett; A Mowat; M A Farquharson; M McGill; C Hind; J Richmond; D Murray; N U Khan; A K Foulis
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

6.  Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.

Authors:  J B Sun; C Rask; T Olsson; J Holmgren; C Czerkinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

7.  Optimizing the germfree mouse model for in vivo evaluation of oral Vibrio cholerae vaccine and vector strains.

Authors:  T I Crean; M John; S B Calderwood; E T Ryan
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

8.  Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine.

Authors:  C Wennerås; A M Svennerholm; C Ahrén; C Czerkinsky
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

9.  The gut as an inductive site for synovial and extra-articular immune responses in rheumatoid arthritis.

Authors:  C Trollmo; C Sollerman; H Carlsten; A Tarkowski
Journal:  Ann Rheum Dis       Date:  1994-06       Impact factor: 19.103

10.  Oral Biologic Delivery: Advances Toward Oral Subunit, DNA, and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics.

Authors:  Jacob William Coffey; Gaurav Das Gaiha; Giovanni Traverso
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-08-31       Impact factor: 13.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.